Qiagen has launched two novel liquid biopsy panels for the evaluation of circulating tumor cells, in the growing field of research into the molecular mechanisms of prostate and lung cancers.
Read More
Progress and challenges are on the way to a blood-based assay for PD-L1.
Read More
Key medical societies are offering new standards for the molecular testing of lung cancers to guide targeted therapies.
Read More
The toolkit from the American Society for Clinical Pathology is designed around actionable topics of tumor acquisition and adequacy, specimen handling and ancillary testing, and interpretation and guidelines.
Read More
Gilupi has shared results of a study examining the detection of circulating tumor cells in the blood of pulmonary disease patients.
Read More